Pulmonary embolism
190 results
1 - 100
Thrombolytic therapy for pulmonary embolism- Imaging for the exclusion of pulmonary embolism in pregnancy
- Anticoagulant treatment for subsegmental pulmonary embolism
- Vena caval filters for the prevention of pulmonary embolism
- D‐dimer test for excluding the diagnosis of pulmonary embolism
- Outpatient versus inpatient treatment for acute pulmonary embolism
- Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism
- Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
- Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Thrombophilia testing for prevention of recurrent venous thromboembolism
- Anticoagulants for people hospitalised with COVID‐19
- Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Compression stockings for preventing deep vein thrombosis in airline passengers
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
- Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
- Interventions for preventing venous thromboembolism following abdominal aortic surgery
- Catheter ablation for paroxysmal and persistent atrial fibrillation: Cochrane systematic review
- Thrombolysis for acute upper extremity deep vein thrombosis
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Anticoagulation for cerebral venous sinus thrombosis: Cochrane systematic review
- Combined oral contraceptives: venous thrombosis
- Topical application of tranexamic acid for the reduction of bleeding
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Anticoagulants for acute ischaemic stroke
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
- Prognostic accuracy of imaging findings for predicting morbidity and mortality in patients with COVID‐19
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
- Anticoagulation for people with cancer and central venous catheters
- Physical methods for preventing deep vein thrombosis in stroke
- Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
- Statins for the primary prevention of venous thromboembolism
- Anticoagulation versus placebo for heart failure in sinus rhythm
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients: Cochrane systematic review
- Methods for administering subcutaneous heparin during pregnancy
- Postoperative tamoxifen for ductal carcinoma in situ
- Graduated compression stockings for prevention of deep vein thrombosis
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Immunoglobulin for multifocal motor neuropathy
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement
- Treatment of distal deep vein thrombosis
- Self‐monitoring and self‐management of oral anticoagulation
- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Prostacyclin for pulmonary arterial hypertension
- Compression therapy for prevention of post‐thrombotic syndrome
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm